4.7 Review

Neurofeedback training in major depressive disorder: A systematic review of clinical efficacy, study quality and reporting practices

期刊

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
卷 125, 期 -, 页码 33-56

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2021.02.015

关键词

Neurofeedback; Biofeedback; Real-time fMRI; Electroencephalography; Functional magnetic resonance imaging; Major depressive disorder; Self-regulation; Neuroimaging

向作者/读者索取更多资源

Neurofeedback training shows potential as an additional treatment option for MDD patients not reaching remission from standard care. Most studies indicate symptom improvement in MDD patients compared to control groups. Recommendations are provided for improving experimental designs and reporting standards in neurofeedback training.
Major depressive disorder (MDD) is the leading cause of disability worldwide. Neurofeedback training has been suggested as a potential additional treatment option for MDD patients not reaching remission from standard care (i.e., psychopharmacology and psychotherapy). Here we systematically reviewed neurofeedback studies employing electroencephalography, or functional magnetic resonance-based protocols in depressive patients. Of 585 initially screened studies, 24 were included in our final sample (N = 480 patients in experimental and N = 194 in the control groups completing the primary endpoint). We evaluated the clinical efficacy across studies and attempted to group studies according to the control condition categories currently used in the field that affect clinical outcomes in group comparisons. In most studies, MDD patients showed symptom improvement superior to the control group(s). However, most articles did not comply with the most stringent study quality and reporting practices. We conclude with recommendations on best practices for experimental designs and reporting standards for neurofeedback training.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据